Research Paper Volume 16, Issue 12 pp 10380—10401
Therapeutic targets of formononetin for treating prostate cancer at the single-cell level
Figure 6. Formononetin altered the expression of its targets in prostate cancer cell line. (A) qPCR analysis showed that formononetin induced the expression of mRNA of TNF, THBS1, HSP90AA1, and HBB in prostate cancer cell. (B) Formononetin treatment also induced the protein level of TNF and reduced the protein level of CD74 in prostate cancer cell.